Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metastatic melanoma of the oral cavity showing prompt regression with the use of BRAF/MEK inhibitors.

The Journal of dermatology - 1 Mar 2024

Oya Kazumasa, Ishizuki Shoichiro, Yasunaga Shiori, Fujisawa Yasuhiro, Nomura Toshifumi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Disease-Free Survival
Share to Melanoma
Share to Mitogen-Activated Protein Kinase Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oximes

Share to Proto-Oncogene Proteins B-raf

Share to Pyridones

Share to Skin Neoplasms

Source

Identifiers

PMID: 37904611
DOI: 10.1111/1346-8138.17019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metastatic melanoma of the oral cavity showing prompt regression with the use of BRAF/MEK inhibitors.PMID 37904611Read ↗

Melanoma of the head and neck: current concepts in diagnosis and management.Semantic proximity Read ↗

Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.Semantic proximity Read ↗

BRAF-MEK inhibition in melanoma brain metastases: a new hope.Semantic proximity Read ↗

Metastatic melanoma: a regional review and future directions.Semantic proximity Read ↗

Mucosal melanoma of the head and neck: a systematic review of the literature.Semantic proximity Read ↗

Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report.Semantic proximity Read ↗

Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy.Semantic proximity Read ↗

BRAF mutation analysis of only one metastatic lesion can restrict the treatment of melanoma: a case report.Semantic proximity Read ↗

Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma.Semantic proximity Read ↗

Head and neck mucosal melanoma: radiological considerations and UK imaging guidelinesSemantic proximity Read ↗

Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.Semantic proximity Read ↗

Impact of BRAF and MEK Inhibitors on Gingival Hyperplasia in Melanoma PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.